ICG Poised to Lead €1.3 Billion Private Loan for Drugmaker SERB

Intermediate Capital Group Plc is poised to lead a group of private credit funds providing a roughly €1.3 billion ($1.5 billion) unitranche loan for Belgian drugmaker SERB Pharmaceuticals, people with knowledge of the matter said.

Blackstone Inc., Goldman Sachs Asset Management and Hayfin Capital Management are among the firms expected to be in the lending syndicate, the people said. The debt will be used to refinance an existing facility.

Pricing is set at 500 basis points over Euribor, with an original issue discount of 98.75 cents on the euro, said the people, who requested anonymity when discussing private matters. ...